Cancer Research

FDA Approves Etcamah for Resistant Metastatic Breast Cancer
Research & Development FDA Approves Etcamah for Resistant Metastatic Breast Cancer

In the United States, 300,000 new cases of breast cancer are diagnosed annually, many of which will eventually progress to a more resistant metastatic state. For patients facing these advanced stages, the traditional arsenal of chemotherapy and hormonal blockers often loses its efficacy over time,

How Is AstraZeneca Redefining the Future of Oncology?
Research & Development How Is AstraZeneca Redefining the Future of Oncology?

The synthesis of combination therapies and early detection creates a feedback loop that amplifies the effectiveness of modern cancer treatment protocols. This paradigm shift means oncologists no longer view cancer as a static entity confined to a single organ like the lung or breast. Instead, they

How Is Dr. Patrick Hwu Transforming the Future of Oncology?
Research & Development How Is Dr. Patrick Hwu Transforming the Future of Oncology?

Under the leadership of Dr. Patrick Hwu, Moffitt Cancer Center is evolving into a facility that prioritizes the rapid translation of laboratory discoveries into clinical products for patient use. This strategic direction stems from a professional journey that began in the unlikely setting of St.

New R Package Geneslator Unifies Genomic Data Mapping
Tech & Innovation New R Package Geneslator Unifies Genomic Data Mapping

Discrepancies in gene nomenclature often force clinicians and computational biologists to struggle with different identifiers for the exact same biological sequence. In the high-stakes environment of 2026, where personalized medicine depends on granular genomic insights, this fragmentation

Strategic Research Initiatives Target Pediatric Brain Tumors
Research & Development Strategic Research Initiatives Target Pediatric Brain Tumors

The interdisciplinary collaboration between biology and chemistry labs is essential for synthesizing new molecules capable of tagging cancer-essential proteins for destruction within the cell. This scientific synergy is particularly vital in the context of pediatric oncology, where the biological

Can Gold Nanorods Revolutionize Targeted Cancer Therapy?
Research & Development Can Gold Nanorods Revolutionize Targeted Cancer Therapy?

When the protein-processing machinery of the endoplasmic reticulum is overwhelmed by external stressors, it triggers a cascade of signaling pathways that culminate in programmed cell death. In the current landscape of 2026, oncology has moved decisively toward these types of organelle-specific

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later